scholarly article | Q13442814 |
P2093 | author name string | Lynn Mubita | |
Theodore H. Schwartz | |||
John W. Kennedy | |||
Vijay K. Anand | |||
Amir R. Dehdashti | |||
Christoph P. Hofstetter | |||
Raaid H. Mannaa | |||
P2860 | cites work | Determinants of clinical outcome and survival in acromegaly | Q72106091 |
Cavernous sinus invasion by pituitary adenoma: MR imaging | Q73746160 | ||
Extended transsphenoidal approach for surgical management of pituitary adenomas invading the cavernous sinus | Q80441097 | ||
Pituitary surgery for the management of acromegaly | Q30306030 | ||
Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. | Q30449349 | ||
Endoscopic transsphenoidal pituitary surgery with intraoperative magnetic resonance imaging | Q33233962 | ||
Endoscopic, endonasal extended transsphenoidal, transplanum transtuberculum approach for resection of suprasellar lesions | Q33279130 | ||
Criteria for cure of acromegaly: a consensus statement | Q33848161 | ||
Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly | Q35041716 | ||
Consensus statement: medical management of acromegaly | Q36328614 | ||
Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations | Q36626499 | ||
Guidelines for acromegaly management: an update | Q37390174 | ||
The natural history of brain contusion: an analysis of radiological and clinical progression. | Q37539930 | ||
A consensus on criteria for cure of acromegaly. | Q37735560 | ||
Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients | Q39711398 | ||
Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly | Q42464202 | ||
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'. | Q42475367 | ||
Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up | Q44088997 | ||
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C | Q46894311 | ||
Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging? | Q48431974 | ||
The ABCs of measuring intracerebral hemorrhage volumes. | Q54430652 | ||
Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas | Q56998863 | ||
Three dimensional staging of breast cancer | Q71810627 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | E6 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | Neurosurgical Focus | Q15759894 |
P1476 | title | Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas | |
Endoscopic endonasal transsphenoidal surgery for growth hormone–secreting pituitary adenomas | |||
P478 | volume | 29 |
Q38694477 | A two-year audit of outcomes of pituitary surgery at an Australian teaching hospital |
Q37913480 | Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission. |
Q39356091 | Acromegaly: surgical results in 548 patients |
Q38252677 | An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly |
Q31126502 | Cavernous Sinus Invasion in Pituitary Adenomas: Systematic Review and Pooled Data Meta-Analysis of Radiologic Criteria and Comparison of Endoscopic and Microscopic Surgery. |
Q54749494 | Double pituitary adenomas are most commonly associated with GH- and ACTH-secreting tumors: systematic review of the literature. |
Q89104595 | Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients |
Q36167107 | Endoscopic Endonasal versus Microsurgical Transsphenoidal Approach for Growth Hormone-Secreting Pituitary Adenomas-Systematic Review and Meta-Analysis. |
Q90171746 | Endoscopic Resection of Pediatric Skull Base Tumors: An Evidence-Based Review |
Q47274589 | Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria |
Q38062441 | Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission |
Q42111803 | Endoscopic endonasal trans-sphenoid surgery of pituitary adenoma |
Q44839557 | Endoscopic transsphenoidal pituitary surgery: a single surgeon experience and the learning curve |
Q38349748 | Endoscopic versus microscopic approach for surgical treatment of acromegaly |
Q30408371 | Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly |
Q54789654 | Intraoperative Scoring System to Predict Postoperative Remission in Endoscopic Endonasal Transsphenoidal Surgery for Growth Hormone-Secreting Pituitary Adenomas. |
Q42510724 | Long term follow-up of growth hormone-secreting pituitary adenomas submitted to endoscopic endonasal surgery |
Q91333639 | Long-Term Effects of Intracapsular Debulking and Adjuvant Somatostatin Analogs for Growth Hormone-Secreting Pituitary Macroadenoma: 10 Years of Experience in a Single Institute |
Q42507980 | Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors |
Q45067448 | Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications |
Q47906659 | Multidisciplinary Approach for Acromegaly: A Single Tertiary Center's Experience. |
Q34749853 | Outcome of endoscopic transsphenoidal surgery in combination with somatostatin analogues in patients with growth hormone producing pituitary adenoma |
Q46335250 | Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients |
Q35173476 | Pro: endoscopic endonasal transsphenoidal pituitary surgery is superior to microscope-based transsphenoidal surgery |
Q34130984 | Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia |
Q89800322 | Random Gh and Igf-I levels after transsphenoidal surgery for acromegaly: relation with long-term remission |
Q38073189 | Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications |
Q37030404 | Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis |
Q38538268 | Surgery induced hypopituitarism in acromegalic patients: a systematic review and meta-analysis of the results |
Q89998885 | Surgical Results and Predictors of Initial and Delayed Remission for Growth Hormone-Secreting Pituitary Adenomas Using the 2010 Consensus Criteria in 162 Patients from a Single Center |
Q36120577 | Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis |
Q38988047 | The surgical treatment of acromegaly. |
Q42458153 | Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays |
Search more.